Published in J Am Geriatr Soc on January 01, 2005
Early identification and treatment of Alzheimer's disease: social and fiscal outcomes. Alzheimers Dement (2009) 1.35
Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors. Can J Psychiatry (2014) 0.98
Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease. Dement Geriatr Cogn Disord (2009) 0.96
Treatment guidelines for Alzheimer's disease: redefining perceptions in primary care. Prim Care Companion J Clin Psychiatry (2007) 0.92
Genetic determinants of disease progression in Alzheimer's disease. J Alzheimers Dis (2015) 0.92
Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine. J Med Chem (2006) 0.88
Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease. Alzheimers Dement (2013) 0.84
Somatic comorbidities and Alzheimer's disease treatment. Neurol Sci (2013) 0.83
Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis. J Neural Transm (Vienna) (2008) 0.83
Donepezil in Alzheimer's disease: an evidence-based review of its impact on clinical and economic outcomes. Core Evid (2006) 0.82
Serious games for screening pre-dementia conditions: from virtuality to reality? A pilot project. Funct Neurol (2014) 0.79
Adding memantine to rivastigmine therapy in patients with mild-to-moderate alzheimer's disease: results of a 12-week, open-label pilot study. Prim Care Companion J Clin Psychiatry (2006) 0.78
Genetic Determinants of Survival in Patientswith Alzheimer’s Disease. J Alzheimers Dis (2015) 0.78
Another data/rhetoric mismatch on donepezil. J Am Geriatr Soc (2005) 0.75
Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease. J Alzheimers Dis (2016) 0.75
Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately? Open Neurol J (2009) 0.75
[New perspectives on Alzheimer's disease from neuroimaging]. Rev Neurol (2010) 0.75
Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes. Dement Geriatr Cogn Dis Extra (2017) 0.75
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol (2006) 11.23
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol (2008) 7.95
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.50
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab (2005) 6.25
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain (2008) 5.89
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 5.55
Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med (2005) 5.10
Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol (2003) 4.82
Chronic traumatic encephalopathy in a National Football League player. Neurosurgery (2005) 4.67
Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology (2004) 3.94
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci (2007) 3.91
Vascular cognitive impairment. Lancet Neurol (2003) 3.73
Evaluation of dementia in the cardiovascular health cognition study. Neuroepidemiology (2003) 3.19
The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry (2004) 3.17
Research evaluation and prospective diagnosis of dementia with Lewy bodies. Arch Neurol (2002) 3.07
The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. Am J Psychiatry (2013) 3.06
Brain structure and obesity. Hum Brain Mapp (2010) 3.04
Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci U S A (2005) 2.79
Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology (2009) 2.70
Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol (2003) 2.70
3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage (2006) 2.69
Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology (2013) 2.61
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA (2009) 2.59
Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage (2005) 2.51
Chronic traumatic encephalopathy in a national football league player: part II. Neurosurgery (2006) 2.40
Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study. Arch Neurol (2007) 2.35
Statistical properties of Jacobian maps and the realization of unbiased large-deformation nonlinear image registration. IEEE Trans Med Imaging (2007) 2.33
Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci (2008) 2.30
Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol (2004) 2.21
Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci (2005) 2.17
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A (2010) 2.12
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci (2003) 2.06
Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet (2011) 2.02
Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol (2003) 1.94
3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS. Neuroimage (2006) 1.93
Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol (2005) 1.92
Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol (2005) 1.91
The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials (2006) 1.88
Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J Clin Invest (2009) 1.87
Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet (2012) 1.79
Tracking Alzheimer's disease. Ann N Y Acad Sci (2007) 1.78
Persistence of neuropsychologic deficits in the remitted state of late-life depression. Am J Geriatr Psychiatry (2006) 1.77
Chronic traumatic encephalopathy (CTE) in a National Football League Player: Case report and emerging medicolegal practice questions. J Forensic Nurs (2010) 1.71
Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry (2002) 1.70
Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol (2003) 1.70
Hemoglobin levels and Alzheimer disease: an epidemiologic study in India. Am J Geriatr Psychiatry (2004) 1.69
Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci (2002) 1.69
Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiol Aging (2010) 1.69
Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease. Neuroimage (2007) 1.68
Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease. J Neuropsychiatry Clin Neurosci (2003) 1.67
Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease. Neuroimage (2006) 1.65
Functional dissociations within the inferior parietal cortex in verbal working memory. Neuroimage (2004) 1.60
Detection and management of cognitive impairment in primary care: The Steel Valley Seniors Survey. J Am Geriatr Soc (2004) 1.59
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.58
Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry (2007) 1.57
Alzheimer disease and mortality: a 15-year epidemiological study. Arch Neurol (2005) 1.55
Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry (2009) 1.54
Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study. AIDS (2004) 1.54
Mean template for tensor-based morphometry using deformation tensors. Med Image Comput Comput Assist Interv (2007) 1.52
Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke (2008) 1.51
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat (2003) 1.50
Imaging of CNS myelin by positron-emission tomography. Proc Natl Acad Sci U S A (2006) 1.49
Patterns of mild cognitive impairment after treatment of depression in the elderly. Am J Geriatr Psychiatry (2009) 1.48
Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry (2011) 1.48
Altered functioning of the executive control circuit in late-life depression: episodic and persistent phenomena. Am J Geriatr Psychiatry (2009) 1.47
Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B. J Neurosci Methods (2008) 1.46
Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. Brain (2010) 1.45
Normative data for determining significance of test-retest differences on eight common neuropsychological instruments. Clin Neuropsychol (2004) 1.44
Infection hospitalization increases risk of dementia in the elderly. Crit Care Med (2014) 1.43
Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients. J Clin Psychopharmacol (2002) 1.41
Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Brain (2013) 1.40
A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. Curr Alzheimer Res (2005) 1.39
22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J Biol Chem (2003) 1.37
Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress. Annu Rev Med (2013) 1.36
Ventricular volume and dementia progression in the Cardiovascular Health Study. Neurobiol Aging (2006) 1.36
Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia. Alzheimer Dis Assoc Disord (2007) 1.35
Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B. Alzheimer Dis Assoc Disord (2008) 1.30